CDC-Enhanced Biobetter

Undoubtedly, biologics have changed treatment; yet, there is a drawback: expense. The development of safe and effective biopharmaceutical medications frequently involves intricate manufacturing processes and quality control, leading to costly end products. As a result, there is a high need for authorized biologics that are therapeutically similar yet less expensive, such as CDC-enhanced biobetter.

With biosimilars being a very competitive market, a lot of businesses are venturing into the biobetter space. A biobetter seeks to offer enhancements while addressing the same targets as current biopharmaceuticals and typically doing so via a similar mechanism of action. "Better" can be attained through structural modifications to the original biologic, including protein fusion, chemical alteration, and changes in amino acids.